Art. 6 Directive (EU) 2001/83

In forcesince 16 Nov 2012cited 184×
1.

No medicinal product may be placed on the market of a Member State unless a marketing authorisation has been issued by the competent authorities of that Member State in accordance with this Directive or an authorisation has been granted in accordance with Regulation (EC) No 726/2004, read in conjunction with Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use [OJ L 378, 27.12.2006, p. 1.] and Regulation (EC) No 1394/2007.

When a medicinal product has been granted an initial marketing authorisation in accordance with the first subparagraph, any additional strengths, pharmaceutical forms, administration routes, presentations, as well as any variations and extensions shall also be granted an authorisation in accordance with the first subparagraph or be included in the initial marketing authorisation. All these marketing authorisations shall be considered as belonging to the same global marketing authorisation, in particular for the purpose of the application of Article 10(1).

1a.

The marketing authorisation holder shall be responsible for marketing the medicinal product. The designation of a representative shall not relieve the marketing authorisation holder of his legal responsibility.

2.

The authorisation referred to in paragraph 1 shall also be required for radionuclide generators, kits, radionuclide precursor radiopharmaceuticals and industrially prepared radiopharmaceuticals.

The 10 that are cited most themselves, of 184.

  • Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…1383Law

    … държава-членка разрешение за търговия в съответствие с член 6 от Директива 2001/83/ЕО. Разрешените лекарствени продукти за хуманна …

  • Judgment of the General Court (Seventh Chamber, Extended Composition) of 5 May 2021. Pharmaceutical Works Polpharma S.A. v European MedicineDecision

    Lastly, it should be noted that, in the implementing decision of 30 January 2014, the Commission found that Tecfidera containing DMF differed from Fumaderm, the other already authorised medicinal product containing DMF and MEF salts, and …

    5 May 2021 · 62018TJ0611

  • Directive (EU) 2004/27Lawamends

  • Judgment of the Court (Fourth Chamber) of 16 March 2023. European Commission and Others v Pharmaceutical Works Polpharma S.A.Decision

    In that regard, it should be noted that, by the decision at issue, the EMA informed Polpharma that it was not in a position to validate its application for a marketing authorisation for a generic medicinal product derived from the …

    16 Mar 2023 · 62021CJ0438

  • Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 Decembe…547Law

    В член 6, параграф 1, първа алинея от Директива 2001/83/ЕО се заменя със следния текст: „1. Лекарствен продукт не може да бъде пуснат на …

  • Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 Novembe…Lawamends

  • Judgment of the Court (Third Chamber), 29 March 2012. European Commission v Republic of Poland.Decisionrelated

    It must be noted at the outset that Article 6(1) of Directive 2001/83 provides that no medicinal product may be placed on the market of a Member State unless a marketing authorisation has been issued by the competent authorities of that …

    29 Mar 2012 · 62010CJ0185

  • Judgment of the Court (Fourth Chamber), 11 April 2013. Novartis Pharma GmbH v Apozyt GmbH.Decision

    Article 6(1) of Directive 2001/83 reads as follows: ‘No medicinal product may be placed on the market of a Member State unless a marketing authorisation has been issued by the competent authorities of that Member State in accordance with …

    11 Apr 2013 · 62011CJ0535

  • Code de la santé publiquel5124-13Law

    … à l'une des conditions suivantes : 1° Il fait l'objet d'une autorisation de mise sur le marché au sens de l'article 6 de la directive 2001/83/ CE du Parlement européen et du Conseil du 6 novembre 2001 instituant un code communautaire …

  • Judgment of the Court (Eighth Chamber) of 28 June 2017. Novartis Europharm Ltd v European Commission.Decision

    Article 6(1) of Directive 2001/83, as amended by Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 (OJ 2006 L 378, p. 1) (‘Directive 2001/83’), provides: ‘No medicinal product may be …

    28 Jun 2017 · 62015CJ0629